Meet Emerald Clinical at AusBiotech 2026
Gold Coast Convention & Exhibition Centre
21 – 23 Oct, 2026
Booth #100
Book a Meeting with Us
Connect with Tamara Murdock, Global Head of Early Phase, Chantal Elbayeh, Executive Director, Project Delivery; and Belinda Morris, Director, Project Delivery at the AusBiotech 2026.
At Emerald Clinical, we understand that Phase I and Proof-of-Concept trials are where programs are made or broken. Emerald Clinical provides services for a wide range of early phase in Australia, China, and the United States, and possesses deep expertise in this field. We have completed more than 840 early phase studies.
The Australian Advantage – A Key Hub for Early Phase
- Emerald Clinical has cultivated a trusted network of early phase sites across Australia, Asia-Pacific, Europe, and North America.
- Streamlined Regulatory – Australia’s CTN scheme enables rapid trial start‑up without an IND, cutting weeks from your timeline.
- Financial Incentives – Up to 43.5% R&D tax rebate on eligible costs, significantly lowering your trial budget.
- World‑Class Infrastructure – Access to top-tier investigators, research professionals, and excellent healthcare facilities.
- International Recognition – Data accepted by the FDA and EMA, smoothing your global regulatory pathway.
Learn More about Australia Tax Incentive Policy
Our Early Phase Services
| First-in-human (FIH) trials | Bioavailability and bioequivalence studies |
| Pharmacokinetics (PK) and pharmacodynamics (PD) assessments | Dose-escalation and proof-of-concept trials |
| Medical Writing Services | Site Identification and Selection |
| Regulatory Coordination | Data Management and Biostatistics |
| Site Management and Monitoring | Vendor Collaboration |
How we have Helped Clients
We combine deep, specialized early phase expertise (FIH to POC) with full service CRO capabilities for both healthy volunteer and patient studies. Our focus on speed and quality means we don’t just accelerate your program — every week you gain speed is a week earlier to market and earlier to market can mean millions in savings.
Book a Meeting with Us
Meet our Team
Learn more about our Early Phase Studies.
Tamara Murdock
Chantal Elbayeh
